Amundi
DGX icon

Amundi’s Quest Diagnostics DGX Stock Holding History

Amundi’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106M Buy
498,751
+90,421
+22% +$17.7M 0.03% 450
2026
Q1 		$80M Sell
408,330
-55,834
-12% -$10.8M 0.02% 490
2025
Q4 		$80.5M Buy
464,164
+36,610
+9% +$6.67M 0.02% 532
2025
Q3 		$76.3M Sell
427,554
-16,008
-4% -$2.84M 0.02% 464
2025
Q2 		$78.3M Sell
443,562
-136,791
-24% -$23.8M 0.03% 468
2025
Q1 		$99M Sell
580,353
-215,132
-27% -$35.3M 0.04% 399
2024
Q4 		$123M Buy
795,485
+77,559
+11% +$12.1M 0.04% 380
2024
Q3 		$107M Sell
717,926
-179,564
-20% -$26.8M 0.04% 386
2024
Q2 		$126M Buy
897,490
+332,965
+59% +$45.6M 0.05% 324
2024
Q1 		$71.1M Buy
564,525
+142,672
+34% +$18.5M 0.03% 445
2023
Q4 		$59.9M Buy
421,853
+18,417
+5% +$2.42M 0.03% 496
2023
Q3 		$49.4M Sell
403,436
-303,965
-43% -$40.5M 0.02% 515
2023
Q2 		$98.8M Sell
707,401
-563,766
-44% -$77.7M 0.05% 361
2023
Q1 		$181M Sell
1,271,167
-204,187
-14% -$29.2M 0.1% 236
2022
Q4 		$229M Buy
1,475,354
+105,471
+8% +$15.2M 0.13% 187
2022
Q3 		$170M Buy
1,369,883
+206,992
+18% +$27.3M 0.1% 219
2022
Q2 		$155M Sell
1,162,891
-150,119
-11% -$20.5M 0.12% 184
2022
Q1 		$180M Sell
1,313,010
-306,291
-19% -$42.7M 0.12% 191
2021
Q4 		$261M Sell
1,619,301
-30,184
-2% -$4.59M 0.17% 150
2021
Q3 		$240M Sell
1,649,485
-54,576
-3% -$7.99M 0.17% 151
2021
Q2 		$225M Buy
+1,704,061
New +$223M 0.16% 157

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Amundi's DGX Position: Q2 2026 in Review

Amundi increased its Quest Diagnostics (DGX) stake by 22% in Q2 2026, buying an estimated $17.7M and bringing the position to 498,751 shares worth $106M. The position accounts for 0.03% of the portfolio, ranked #450.

Amundi first reported a position in DGX in Q2 2021 and has held it in 21 quarters since. The position peaked at $261M in Q4 2021. 1,106 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Amundi held 498,751 shares of Quest Diagnostics worth $106M as of Q2 2026.
  • Amundi bought 90,421 Quest Diagnostics shares in Q2 2026, an estimated $17.7M.
  • Quest Diagnostics made up 0.03% of Amundi's portfolio in Q2 2026, its #450 holding.
  • Amundi first reported a position in Quest Diagnostics in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Quest Diagnostics position peaked at $261M in Q4 2021.
  • 1,106 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.